Muscle-Saving supplement tested in kidney patients
NCT ID NCT07374042
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a ketoanalogue supplement (Ketosteril) can prevent muscle loss in 100 adults with stage 4 or 5 chronic kidney disease who are on a moderately low-protein diet. Participants take the supplement daily for a period, and researchers measure changes in muscle mass using DEXA scans. The goal is to find a way to help patients maintain strength and delay the need for dialysis.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
keto acid analog (Ketosteril)
What this could lead to
If it works, this could offer a way to protect muscle mass in people with advanced kidney disease, potentially delaying the need for dialysis.
What could go wrong
This is a phase 3 trial, but it's still relatively small (100 participants) and focuses on a specific patient group. The supplement may not prevent muscle loss, and some people may find the diet hard to follow.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE STAGE 5 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU de Clermont-Ferrand
RECRUITINGClermont-Ferrand, 63000, France
Contact
Contact Email: •••••@•••••